Surgeons at Toronto General Hospital performed the first live medical procedure using real-time holographic imaging developed by Israel’s RealView Imaging (see here). The 3D images allowed the surgeons to see inside the heart prior to a mitral valve replacement procedure. … Continue reading →

I’ve reported previously (see here) on the many Israeli innovations that are trying to prevent antibiotics from becoming ineffective. Now Israeli startup Nanosynex offers a 4-hour test to determine which antibiotic will be effective and what dose to use to … Continue reading →

Avi Yavetz from Modi’in suffers from peripheral vascular disease (PVD) and a leg amputation was imminent. However, his son, 27-year-old Snir donated a long vein, which was implanted into his father in a first of its kind operation. Two weeks … Continue reading →

I reported previously (Mar 2015) on the computer interface device from Israel’s Neurosteer used to monitor brain activity. The three-strip wearable device is now in clinical trials in Israel, Europe and the United States and proving far simpler and more … Continue reading →

I reported previously (Apr 2017) on the innovative FasTouch fixation system from Israel’s Via Surgical for hernia repairs. The company has just announced that it has received US FDA approval for the system. https://www.prnewswire.com/news-releases/via-surgical-receives-fda-clearance-for-its-fastouch-absorbable-fixation-system-300813799.html http://viasurgical.com/science/

I reported previously (Apr 2018) when Israel’s Endospan received the CE mark for its Horizon stent graft system to treat Abdominal Aortic Aneurysm. It now also has received the CE mark for its Nexus Stent Graft System to treat Aortic … Continue reading →

I reported previously (Oct 2016) on the Nerivio Migra smart patch from Israel’s Theranica to provide migraine relief. Since then, Theranica has successfully completed a 12-center pivotal study of the patch and has raised $35 million for US FDA approval … Continue reading →

I reported previously (Jun 2015) on the PregSense wearable fetal monitor from Israel’s Nuvo. Renamed Invu,,multi-center trials produced fetal and maternal heart rates comparable to existing standalone cardiotocographs (CTGs). US FDA review is in progress. https://www.prnewswire.com/news-releases/nuvo-group-ltd-presents-data-on-remote-monitoring-in-pregnancy-at-the-66th-annual-society-for-reproductive-investigation-sri-meeting-300813907.html

I reported previously (Oct 2014) that the Aramchol treatment from Israel’s Galmed for Non-Alcoholic Steatohepatitis (NASH) had been fast-tracked by the US FDA. Latest trials show that twice-daily dosages of Aramchol significantly increased blood plasma levels. http://galmedpharma.investorroom.com/2019-03-12-Galmed-Reports-Positive-Results-From-Pharmacokinetic-Split-Dose-Study-of-Aramchol

The 3rd episode of Israel’s Weizmann in Focus, highlights that, since October, 7.3 million Americans have been sick with the flu virus with over 80,000 hospitalized. Weizmann Professor Ruth Arnon’s work has led to the development of the Universal Flu … Continue reading →